JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265832

Human CASC4 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

GOLM2 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and 1 bp insertion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
2 Images
Sanger Sequencing - Human CASC4 knockout HeLa cell line (AB265832)
  • Sanger seq

Unknown

Sanger Sequencing - Human CASC4 knockout HeLa cell line (AB265832)

Allele-1 : 1 bp deletion in exon 1.

Sanger Sequencing - Human CASC4 knockout HeLa cell line (AB265832)
  • Sanger seq

Unknown

Sanger Sequencing - Human CASC4 knockout HeLa cell line (AB265832)

Allele-2 : 1 bp insertion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and 1 bp insertion in exon 1

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265832-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265832-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265832 Human CASC4 knockout HeLa cell line", "number":"AB265832-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265832-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265832-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265832 Human CASC4 knockout HeLa cell line", "number":"AB265832-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265832-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265832 Human CASC4 knockout HeLa cell line", "number":"AB265832-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265832-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265832 Human CASC4 knockout HeLa cell line", "number":"AB265832-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
GOLM2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CASC4 short for Cancer Susceptibility Candidate 4 is a protein involved in cell processes with a mass of approximately 87 kDa. It is expressed in various tissues with higher levels observed in specific cancer types. Its exact mechanical role in cells includes interactions and binding to other cellular elements influencing cell functions and stability. Researchers usually study this protein by its official name due to its relevance in cancer studies and its interaction potentials in cellular mechanisms.
Biological function summary

The protein plays a role in cellular growth and regulation. It is part of a larger complex that includes other signaling and structural proteins supporting its function in maintaining proper cellular environments. It may help ensure the cell cycle progresses smoothly influencing cell survival and replication. Its expression suggests it might help modulate responses under stress or during abnormal growth which can have implications for understanding certain cancer behaviors.

Pathways

CASC4 engages in cellular signaling and growth regulation pathways specifically those related to cancer biology. It is involved in pathways such as the PI3K/AKT pathway which is important for cell proliferation and survival. In these networks CASC4 connects with other proteins like AKT potentially influencing the pathway's outcomes on cell fate decisions and tumor progression. This interaction suggests that CASC4 may have a role in modifying signaling outcomes depending on different cellular contexts.

Research indicates that CASC4 is associated with cancer progression and certain subtypes like breast and colorectal cancers. These associations hint that abnormal expression or functioning of CASC4 could contribute to oncogenic processes. It often interacts with proteins like PTEN in these disease contexts emphasizing its potential impact on tumor suppression or promotion. Understanding these interactions could prove beneficial in developing targeted therapies or diagnostic markers for these cancers.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com